Long-term outcome of surgically treated and conservatively managed Rathke cleft cysts.

Endocrinological outcome Functional outcome Rathke cleft cysts Secondary cyst progression Transsphenoidal approach

Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 23 12 2023
accepted: 21 03 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: epublish

Résumé

Rathke cleft cysts (RCC) are benign lesions of the sellar region that require surgical treatment in case of visual deterioration or progression of the cyst. However, the natural course is often stable and asymptomatic. We aimed to investigate the characteristics of patients with cyst progression during follow-up (FU) and to compare the natural history of patients with RCC with patients who underwent surgery. Patients with an MR morphologic cystic sellar lesion classified as RCC between 04/2001 and 11/2020 were included. Functional outcomes, including ophthalmologic, endocrinologic, and MRI data, were retrospectively analyzed and compared between surgically treated patients, patients on a "watch and wait" strategy (WWS), and patients on a WWS who underwent secondary surgery due to cyst progression. One hundred forty patients (median age 42.8 years) with RCC on MRI were identified. 52/140 (37.1%) underwent primary surgery. Of 88 patients (62.9%) with initial WWS, 21 (23.9%) underwent surgery for secondary cyst progression. Patients on the WWS had significantly smaller cyst volumes (p = 0.0001) and fewer visual disturbances (p = 0.0004), but a similar rate of hormone deficiencies (p = 0.99) compared with surgically treated patients preoperatively. Postoperatively patients suffered significantly more often from hormone deficiencies than WWS patients (p = 0.001). Patients who switched to the surgical group were significantly more likely to have preoperative T1 hyperintense signals on MRI (p = 0.0001) and visual disturbances (p = 0.001) than patients with continuous WWS. Postoperatively, these patients suffered more frequently from new hormonal deficiencies (p = 0.001). Endocrine and ophthalmologic outcomes in patients with primary and secondary surgery were comparable. Multivariate analysis showed that WWS patients were at a higher risk of requiring surgery for cyst progression when perimetric deficits (p = 0.006), hyperprolactinemia (p = 0.003), and corticotropic deficits (p = 0.005) were present. Surgical treatment of RCC may cause new hormonal deficiencies, which are rare in the natural course. Therefore, the indication for surgery should be carefully evaluated. Hyperprolactinemia and corticotropic deficits were significant indicators for a secondary cyst progression in patients with RCC. However, a significant amount of almost 25% of initially conservatively managed cysts showed deterioration, necessary for surgical intervention.

Identifiants

pubmed: 38557782
doi: 10.1007/s00701-024-06052-8
pii: 10.1007/s00701-024-06052-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159

Informations de copyright

© 2024. The Author(s).

Références

Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102:189–193. https://doi.org/10.3171/jns.2005.102.2.0189
doi: 10.3171/jns.2005.102.2.0189 pubmed: 15739543
Barkhoudarian G, Palejwala SK, Ansari S, Eisenberg AA, Huang X, Griffiths CF, Cohan P, Rettinger S, Lavin N, Kelly DF (2019) Rathke’s cleft cysts: a 6-year experience of surgery vs. observation with comparative volumetric analysis. Pituitary 22:362–371. https://doi.org/10.1007/s11102-019-00962-y
doi: 10.1007/s11102-019-00962-y pubmed: 31016554
Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD (2004) Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg 101:577–584. https://doi.org/10.3171/jns.2004.101.4.0577
doi: 10.3171/jns.2004.101.4.0577 pubmed: 15481709
Byun WM, Kim OL, Kim D (2000) MR imaging findings of Rathke’s cleft cysts: significance of intracystic nodules. AJNR Am J Neuroradiol 21:485–488
pubmed: 10730639 pmcid: 8174989
Castle-Kirszbaum M, Kam J, Wang YY, King J, Fryer K, Goldschlager T (2022) Surgical outcomes and quality of life in Rathke’s cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature. Pituitary 25:285–295. https://doi.org/10.1007/s11102-021-01197-6
doi: 10.1007/s11102-021-01197-6 pubmed: 35001297
Chong GYC, Tan KCB, Lau EYF, Lai AYT, Man KKY, Chan TM, Leung WKW, Leung JYY (2022) A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively. Pituitary 25:258–266. https://doi.org/10.1007/s11102-021-01194-9
doi: 10.1007/s11102-021-01194-9 pubmed: 34807360
Culver SA, Grober Y, Ornan DA, Patrie JT, Oldfield EH, Jane JA Jr, Thorner MO (2015) A case for conservative management: characterizing the natural history of radiographically diagnosed Rathke cleft cysts. J Clin Endocrinol Metab 100:3943–3948. https://doi.org/10.1210/jc.2015-2604
doi: 10.1210/jc.2015-2604 pubmed: 26305621 pmcid: 5399501
Eymann R, Kiefer M (2018) Rathke-Zyste, Kraniopharyngeom und Kolloidzyste. Radiologe 58:646–652. https://doi.org/10.1007/s00117-018-0398-0
doi: 10.1007/s00117-018-0398-0 pubmed: 29777270
Fukui I, Hayashi Y, Kita D, Sasagawa Y, Oishi M, Tachibana O, Nakada M (2017) Significant improvement in chronic persistent headaches caused by small Rathke cleft cysts after transsphenoidal surgery. World Neurosurg 99:362–368. https://doi.org/10.1016/j.wneu.2016.12.111
doi: 10.1016/j.wneu.2016.12.111 pubmed: 28057594
Iqbal J, Kanaan I, Al Homsi M (1999) Non-neoplastic cystic lesions of the sellar region presentation, diagnosis and management of eight cases and review of the literature. Acta Neurochir (Wien) 141:389–397; discussion 397–388. https://doi.org/10.1007/s007010050315
Kim JE, Kim JH, Kim OL, Paek SH, Kim DG, Chi JG, Jung HW (2004) Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence. J Neurosurg 100:33–40. https://doi.org/10.3171/jns.2004.100.1.0033
doi: 10.3171/jns.2004.100.1.0033 pubmed: 14743909
Kinoshita Y, Taguchi A, Yamasaki F, Tominaga A, Arita K, Horie N (2023) Natural course of Rathke’s cleft cysts and risk factors for progression. J Neurosurg 138:1426–1432. https://doi.org/10.3171/2022.7.JNS22716
doi: 10.3171/2022.7.JNS22716 pubmed: 36057119
Kinoshita Y, Tominaga A, Usui S, Arita K, Sakoguchi T, Sugiyama K, Kurisu K (2016) The long-term recurrence of Rathke’s cleft cysts as predicted by histology but not by surgical procedure. J Neurosurg 125:1002–1007. https://doi.org/10.3171/2015.8.JNS151282
doi: 10.3171/2015.8.JNS151282 pubmed: 26771852
Kumar M, Dutta D, Shivaprasad KS, Jain R, Sen A, Biswas D, Mukhopadhyay M, Ghosh S, Mukhopadhyay S, Chowdhury S (2013) Diabetes insipidus as a presenting manifestation of Rathke’s cleft cyst. Indian J Endocrinol Metab 17:S127-129. https://doi.org/10.4103/2230-8210.119529
doi: 10.4103/2230-8210.119529 pubmed: 24251131 pmcid: 3830277
Mendelson ZS, Husain Q, Elmoursi S, Svider PF, Eloy JA, Liu JK (2014) Rathke’s cleft cyst recurrence after transsphenoidal surgery: a meta-analysis of 1151 cases. J Clin Neurosci 21:378–385. https://doi.org/10.1016/j.jocn.2013.07.008
doi: 10.1016/j.jocn.2013.07.008 pubmed: 24269553
Nishioka H, Haraoka J, Izawa H, Ikeda Y (2006) Headaches associated with Rathke’s cleft cyst. Headache 46:1580–1586. https://doi.org/10.1111/j.1526-4610.2006.00539.x
doi: 10.1111/j.1526-4610.2006.00539.x pubmed: 17115992
Petersson M, Berinder K, Eden Engstrom B, Tsatsaris E, Ekman B, Wahlberg J, Burman P, Borg H, Siesjo P, Dahlqvist P, Akerman AK, Ragnarsson O, Olsson M, Forander P, Bensing S, Hoybye C (2022) Natural history and surgical outcome of Rathke’s cleft cysts-a study from the Swedish Pituitary Registry. Clin Endocrinol (Oxf) 96:54–61. https://doi.org/10.1111/cen.14622
doi: 10.1111/cen.14622 pubmed: 34724249
Ratha V, Patil S, Karmarkar VS, Shah NJ, Deopujari CE (2017) Surgical management of Rathke cleft cysts. World Neurosurg 107:276–284. https://doi.org/10.1016/j.wneu.2017.07.164
doi: 10.1016/j.wneu.2017.07.164 pubmed: 28826711
Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203–216. https://doi.org/10.1530/eje.1.02326
doi: 10.1530/eje.1.02326 pubmed: 17287410
Sala E, Moore JM, Amorin A, Carosi G, Martinez H Jr, Harsh GR, Arosio M, Mantovani G, Katznelson L (2018) Natural history of Rathke’s cleft cysts: a retrospective analysis of a two centres experience. Clin Endocrinol (Oxf) 89:178–186. https://doi.org/10.1111/cen.13744
doi: 10.1111/cen.13744 pubmed: 29781512
Schmutzer M, Thorsteinsdottir J, Weller J, Rachinger W, Schichor C, Thon N, Ueberschaer M (2023) Nuclear translocation of beta catenin in patients with Rathke cleft cysts-clinical and imaging characteristics and risk of recurrence. Acta Neurochir (Wien). https://doi.org/10.1007/s00701-023-05733-0
doi: 10.1007/s00701-023-05733-0 pubmed: 37676505
Shepard MJ, Elzoghby MA, Kiehna EN, Payne SC, Jane JA (2018) Presentation and outcomes in surgically and conservatively managed pediatric Rathke cleft cysts. J Neurosurg Pediatr 21:308–314. https://doi.org/10.3171/2017.9.PEDS17400
doi: 10.3171/2017.9.PEDS17400 pubmed: 29271731
Teramoto A, Hirakawa K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193:161–164. https://doi.org/10.1148/radiology.193.1.8090885
doi: 10.1148/radiology.193.1.8090885 pubmed: 8090885
Trifanescu R, Ansorge O, Wass JA, Grossman AB, Karavitaki N (2012) Rathke’s cleft cysts. Clin Endocrinol (Oxf) 76:151–160. https://doi.org/10.1111/j.1365-2265.2011.04235.x
doi: 10.1111/j.1365-2265.2011.04235.x pubmed: 21951110
Truong LUF, Bazin C, Gomis P, Decoudier B, Delemer B, Litre CF (2021) Surgery versus conservative care for Rathke’s cleft cyst. Neurochirurgie 67:104–111. https://doi.org/10.1016/j.neuchi.2020.12.010
doi: 10.1016/j.neuchi.2020.12.010 pubmed: 33450264
Wang S, Nie Q, Wu Z, Zhang J, Wei L (2020) MRI and pathological features of Rathke cleft cysts in the sellar region. Exp Ther Med 19:611–618. https://doi.org/10.3892/etm.2019.8272
doi: 10.3892/etm.2019.8272 pubmed: 31897104
Wedemeyer MA, Lin M, Fredrickson VL, Arakelyan A, Bradley D, Donoho DA, Hurth KM, Weiss MH, Carmichael JD, Zada G (2019) Recurrent Rathke’s cleft cysts: incidence and surgical management in a tertiary pituitary center over 2 decades. Oper Neurosurg (Hagerstown) 16:675–684. https://doi.org/10.1093/ons/opy258
doi: 10.1093/ons/opy258 pubmed: 30247673
Zada G (2011) Rathke cleft cysts: a review of clinical and surgical management. Neurosurg Focus 31:E1. https://doi.org/10.3171/2011.5.FOCUS1183
doi: 10.3171/2011.5.FOCUS1183 pubmed: 21721866

Auteurs

Michael Schmutzer-Sondergeld (M)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany. michael.schmutzer@med.uni-muenchen.de.

Jonathan Weller (J)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.

Jun Thorsteinsdottir (J)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.

Christian Schichor (C)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.

Walter Rachinger (W)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.

Niklas Thon (N)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.

Moritz Ueberschaer (M)

Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.

Classifications MeSH